Speculation about the fallout from Pfizer ($PFE) and Allergan's ($AGN) $160 billion megamerger has begun. The San Francisco Business Times put together a list of companies that could be affected by the deal that includes NuMedii, the digital drug discovery player that struck a collaboration with Allergan in September. Article